Capivasertib-paclitaxel fails to improve overall survival in metastatic TNBC
New drug combo did not extend life for metastatic triple-negative breast cancer patients in this trial
This phase III RCT in 812 patients with previously untreated metastatic triple-negative breast cancer found that adding capivasertib to pacl…
A large global trial found that adding capivasertib to paclitaxel did not improve overall survival for patients with metastatic triple-negat…
Atezolizumab plus chemotherapy improved progression-free survival and patient-reported quality of life in metastatic triple-negative breast cancer
Adding atezolizumab to chemotherapy improved quality of life and survival in some patients with metastatic triple-negative breast cancer
This randomized trial evaluated adding atezolizumab to anthracycline-based chemotherapy versus chemotherapy plus placebo in patients with me…
Adding atezolizumab to chemotherapy improved quality of life, emotional functioning, and pain for patients with metastatic triple-negative b…
PSMA PET/CT shows uptake in half of metastatic triple-negative breast cancer patients
Can a prostate cancer scan help treat aggressive breast cancer?
A prospective single-center study of 20 patients with progressive mTNBC found that 50% showed visual PSMA positivity on [Ga]Ga-PSMA-11 PET/C…
A prostate cancer scan found PSMA targets in half of aggressive breast cancer tumors, suggesting a new therapy option for patients when stan…